Improving ICU care for patients who speak languages other than English
Examination of Health Disparities in ICU Delirium Prevention and Management for Patients Who Speak A Language Other Than English
This study is looking at how to better support non-English speaking patients in the ICU by making sure they get the right care and communication, so they can feel more comfortable and safe during their treatment.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10995139 on NIH RePORTER |
What this research studies
This research focuses on enhancing the prevention and management of delirium in Intensive Care Unit (ICU) patients who do not speak English. It aims to address health disparities by ensuring that these patients receive comprehensive care through the ABCDEF bundle, which includes pain assessment, sedation choices, and family engagement. The study will explore the barriers faced by non-English speaking patients in accessing these critical components of care, particularly the lack of professional medical interpreters. By identifying and addressing these barriers, the research seeks to improve health equity in critical care settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are critically ill patients in the ICU who speak a language other than English.
Not a fit: Patients who are fluent in English or those who are not critically ill may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better outcomes for non-English speaking ICU patients by ensuring they receive appropriate delirium prevention and management.
How similar studies have performed: Previous research has highlighted the importance of effective communication in healthcare, suggesting that addressing language barriers can significantly improve patient outcomes.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Ahrens, Emily — University of Washington
- Study coordinator: Ahrens, Emily
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.